You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

CARVEDILOL PHOSPHATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Carvedilol Phosphate patents expire, and when can generic versions of Carvedilol Phosphate launch?

Carvedilol Phosphate is a drug marketed by Impax Labs Inc and Sun Pharm Industries and is included in two NDAs.

The generic ingredient in CARVEDILOL PHOSPHATE is carvedilol phosphate. There are thirty-seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the carvedilol phosphate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Carvedilol Phosphate

A generic version of CARVEDILOL PHOSPHATE was approved as carvedilol phosphate by SUN PHARM INDUSTRIES on October 25th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CARVEDILOL PHOSPHATE?
  • What are the global sales for CARVEDILOL PHOSPHATE?
  • What is Average Wholesale Price for CARVEDILOL PHOSPHATE?
Drug patent expirations by year for CARVEDILOL PHOSPHATE
Recent Clinical Trials for CARVEDILOL PHOSPHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 1
University of Minnesota - Clinical and Translational Science InstitutePhase 1/Phase 2
University of MinnesotaPhase 1/Phase 2

See all CARVEDILOL PHOSPHATE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for CARVEDILOL PHOSPHATE
Paragraph IV (Patent) Challenges for CARVEDILOL PHOSPHATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
COREG CR Extended-release Capsules carvedilol phosphate 10 mg and 20 mg 022012 1 2008-03-18
COREG CR Extended-release Capsules carvedilol phosphate 40 mg 022012 1 2007-12-21
COREG CR Extended-release Capsules carvedilol phosphate 80 mg 022012 1 2007-11-19

US Patents and Regulatory Information for CARVEDILOL PHOSPHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc CARVEDILOL PHOSPHATE carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 204717-001 May 7, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Industries CARVEDILOL PHOSPHATE carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 090132-003 Oct 25, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Impax Labs Inc CARVEDILOL PHOSPHATE carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 204717-004 May 7, 2018 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Industries CARVEDILOL PHOSPHATE carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 090132-004 Oct 25, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.